According to the research report titled ‘Drug Abuse Testing Market to 2027 - Global Analysis and Forecasts by Product (Rapid Testing Devices, Analyzers and Consumables); Sample Type (Blood, Urine, Saliva and Other Sample Types); End User (Hospitals, Diagnostic Laboratories and Forensic Laboratories) and Geography’ available at MarketStudyReport.com, the global drug abuse testing market was worth US $5783.71 million in 2018 and is expected to grow with a CAGR of 5.7% during the period of 2019-2027, hence reaching US $9393.17 million by the year 2027.
 

For the record, drug abuse testing involves detection of multiple drugs in blood, urine, saliva, sweat or hair. Rising illicit drugs consumption, coupled with strict federal regulation towards drug use, and initiatives taken to create awareness regarding drug abuse are driving the growth of the drug abuse testing market for the forecast period. Increasing marijuana and alcohol consumption and surging need of drug diagnostic devices are further aiding the market growth. However, scarcity of skilled laboratory professionals may hinder the drug abuse testing market outlook to some extent.
 

According to NSDUH (National Household Survey on Drug Abuse), up to 19.7 million American adults experienced drug abuse in 2017. SAMHSAM also specified that marijuana is considered as Schedule I drug and is stated to be having a high potential for drug abuse. Since the laws regarding the use of marijuana have changed across the globe, marijuana related substance abuse has increased significantly. These factors are augmenting the demand for drug abuse testing devices across the globe.
 

Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/2202035/
 

As per product, drug abuse testing market is categorized into analyzers, rapid testing devices, and consumables, whereas in terms of sample type, the market is classified into saliva, urine, blood, and others. On the basis of end-user spectrum, the industry is bifurcated into diagnostic laboratories, hospitals, and forensic laboratories.
 

The prominent players operating in the global drug abuse testing market are UCP Biosciences, OraSure Technologies, Inc., MEDACX Ltd., Wondfo, Beckman Coulter, Inc. (Danaher), Redwood Toxicology Laboratory (Abbott), Siemens, F. Hoffmann-La Roche Ltd., Drägerwerk AG & Co. KGaA, Thermo Fisher Scientific, Inc., Mercedes Medical, American Screening Corp., Inc., Express Diagnostics International Inc., Alfa Scientific Designs Inc., Laboratório Sodré, and Omega Laboratories, Inc.